Skip to main content

Table 1 Patients characteristics and treatments at diagnosis

From: Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma

  No. (%)
Sex
 Female 21 (49)
 Male 22 (51)
Median age years (range) 51 (27–80)
MGMT promoter methylation status
 Methylated 18 (42)
 Unmethylated 8 (19)
 Unknown 17 (39)
IDH mutation
 Present 6 (14)
 Absent 20 (47)
 Unknown 17 (39)
KPS
 100 11 (26)
 90 19 (44)
 80 2 (4)
 70 11 (26)
Time to Relapse from initial diagnosis
  ≤ 12 months 21 (49)
  > 12–24 months 13 (30)
  > 24 months 9 (21)
Treatment at Initial Diagnosis
 Surgery 43 (100)
 Complete Resection (CR) 24 (56)
 Subtotal Resection (SR) 5 (12)
 Partial Resection (PR) 12 (28)
 Biopsy 2 (4)
 Radiotherapy 43 (100)
 CT Concomitant and adjuvant (TMZ) 43 (100)
  1. MGMT methylguanine-DNA methyltransferase, IDH isocitrate dehydrogenase, KPS karnofsky performance status, TMZ Temozolomide